Skip to main content
Log in

Nitric Oxide Inhibits INFγ-induced Increases in CIITA mRNA Abundance and Activation of CIITA Dependent Genes—Class II MHC, Ii and H-2M

  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Background: Nitric oxide (NO) has been recently implicated as a powerful inhibitor of immune responses during allograft rejection, and some autoimmune and infectious diseases. We previously showed that one potential regulatory effect of NO is inhibition of IFNγ-stimulated expression of Class II MHC on macrophages. Activation of this gene is mediated by the "Class II TransActivator" (CIITA). We now ask whether NO inhibits CIITA and thus the family of genes regulated by CIITA—Class II MHC, Ii, and H-2M. The latter two genes participate in antigen processing and formation of the cell-surface peptide-Class II MHC complex. Methods: Murine macrophages—both peritoneal macrophages and the RAW264.7 macrophage line—were stimulated in vitro with IFNγ. NO production was measured by the Greiss reagent. Transcription of Class II MHC was measured by nuclear run-on assay. mRNA abundance of Class II MHC, Ii, H-2M, and CIITA was measured by Northern blotting and RT-PCR. Results: NO inhibits IFNγ-induced increases in the abundance and transcription of the Class II MHC Ab gene. The increases in mRNA abundance of CIITA, Ii, and H-2M are also inhibited. As a control, we found that NO did not inhibit LPS-induce increases in TNFα mRNA abundance. Conclusions: NO inhibits IFNγ-induced increases in CIITA, and thus inhibits the CIITA-regulated genes: Class II MHC, Ii, and H-2M. Early during rejection, NO production by macrophages may result after stimulation by IFNγ produced by CD4+ T cells, and be an effector of allograft damage. High concentrations of NO may then act as a feedback inhibitor which decreases antigen presentation by macrophages and thus decreases CD4 T cell activation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. SZABOLCS, M., S. RAVALLI, O. MINANOV, R. R. SCIACCA, R. E. MICHLER, and P. J. CANNON. 1998. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation 65:804-812.

    Google Scholar 

  2. MACMICKING, J., Q. W. XIE, and C. NATHAN. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323-350.

    Google Scholar 

  3. IOANNIDIS, I., A. HELLINGER, C. DEHMLOW, U. RAUEN, J. ERHARD, F. W. EIGLER, and H. DEGROOT. 1995. Evidence for increased nitric oxide production after liver transplantation in humans. Transplantation 59:1293-1297.

    Google Scholar 

  4. DEVLIN, J., R. M. PALMER, C. E. GONDE, J. O'GRADY, N. HEATON, K. C. TAN, J. F. MARTIN, S. MONCADA, and R. WILLIAMS. 1994. Nitric oxide generation. A predictive parameter of acute allograft rejection. Transplantation 58: 592-595.

    Google Scholar 

  5. SMITH, S. D., M. A. WHEELER, R. ZHANG, E. D. WEISS, M. L. LORBER, W. C. SESSA, and R. M. WEISS. 1996. Nitric oxide synthase induction with renal transplant rejection or infection. Kidney Int. 50:2088-2093.

    Google Scholar 

  6. BOGDAN, C. 1998. Commentary: The multiplex function of nitric oxide in (Auto) immunity. J. Exp. Med. 187:1361-1365.

    Google Scholar 

  7. GABBAI, F. B., C. BOGGIANO, T. PETER, S. KHANG, C. ARCHER, D. P. GOLD, and C. J. KELLY. 1997. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis. J. Immunol. 159:6266-6275.

    Google Scholar 

  8. LANGREHR, J. M., R. A. HOFFMAN, J. R. JR. LANCASTER, and R. L. SIMMONS. 1993. Nitric oxide-a new endogenous immunomodulator. Transplantation 55:1205-1212.

    Google Scholar 

  9. STOJANOVIC, T., H. J. GRONE, R. K. H. GIESELER, B. KLANKE, R. SCHLEMMINGER, D. TSIKAS, and E. F. GRONE. 1996. Enhanced renal allograft rejection by inhibitors of nitric oxide synthase: a nonimmunologic influence on alloreactivity. Lab. Invest. 74:496-512.

    Google Scholar 

  10. SHEARS, L. L. I., N. KAWAHARADA, E. TZENG, T. R. BILLIAR, S. C. WATKINS, I. KOVESDI, A. LIZONOVA, and S. M. PHAM. 1997. Inducible nitric oxide synthase suppresses the development of allograft atherosclerosis. J. Clin. Invest. 100:2035-2042.

    Google Scholar 

  11. KOGLIN, J., T. GLYSING-JENSEN, J. S. MUDGETT, and M. E. RUSSELL. 1998. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection: insights from NOS2-knockout mice. Am. J. Pathol. 153:1371-1376.

    Google Scholar 

  12. KOGLIN, J., T. GLYSING-JENSEN, J. S. MUDGETT, and M. E. RUSSELL. 1998. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circul. 97:2059-2065.

    Google Scholar 

  13. SICHER, S. C., VAZQUEZ, M. A., and LU, C. Y. 1994. Inhibition of macrophage Ia expression by nitric oxide. J. Immunol. 153:1293-1300.

    Google Scholar 

  14. SICHER, S. C., G. W. CHUNG, M. A. VAZQUEZ, and C. Y. LU. 1995. Augmentation or inhibition of IFN-gamma-induced MHC class II expression by lipopolysaccharides: the roles of TNF-alpha and nitric oxide, and the importance of the sequence of signaling. J. Immunol. 155:5826-5834.

    Google Scholar 

  15. HEUSCHLING, P. 1995. Nitric oxide modulates gamma-interferon-induced MHC class II antigen expression on rat astrocytes. J. Neuroimmunol. 35:63-69.

    Google Scholar 

  16. HOLT, P. G., J. OLIVER, N. BILYK, C. NCMENAMIN, K. G. MCMENAMIN, and T. THEPEN. 1993. Downregulation of the antigen presenting cell function(s) of pulmonary dendritic cells in vivo by resident alveolar macrophages. J. Exp. Med. 177:397-407.

    Google Scholar 

  17. AYALA, A., W. ERTEL, and I. H. CHAUDRY. 1996. Trauma-induced suppression of antigen presentation and expression of major histocompatibility class II antigen complex in leukocytes. Shock 5:79-90.

    Google Scholar 

  18. UNANUE, E. R. and P. M. ALLEN. 1987. The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236:551-557.

    Google Scholar 

  19. GREGORY, S. H., E. J. WING, R. A. HOFFMAN, and R. L. SIMMONS. 1993. Reactive nitrogen intermediates suppress the primary immunologic response to listeria. J. Immunol. 150:2901-2909.

    Google Scholar 

  20. MACH, B., V. STEIMLE, E. MARTINEZ-SORIA, and W. REITH. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14:301-331.

    Google Scholar 

  21. CRESSWELL, P. 1996. Invariant chain structure and MHC class II function. Cell 84:505-507.

    Google Scholar 

  22. CEMAN, S., and A. J. SANT. 1996. The function of invariant chain in class II-restricted antigen presentation. Semin. Immunol. 7: 373-387.

    Google Scholar 

  23. KROPSHOFER, H., G. J. HAMMERLING, and A. B. BOGT. 1997. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol. Today 18:77-82.

    Google Scholar 

  24. SLOAN, V. S., P. CAMERON, G. PORTER, M. GAMMON, M. AMAYA, E. MELLINS, and D. M. ZALLER. 1995. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375:802-806.

    Google Scholar 

  25. DENZIN, L. K., P. CRESSWELL. 1998. HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 82:155-165.

    Google Scholar 

  26. SHERMAN, M. A., D. A. WEBER, and P. E. JENSEN. 1998. DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. Immunity 3:197-205.

    Google Scholar 

  27. VIVILLE, S., J. NEEFJES, V. LOTTEAU, A. DIERICH, M. LEMEUR, H. PLOEGH, C. BENOIST, and D. MATHIS. 1993. Mice lacking the MHC class II-associated invariant chain. Cell 72:635-648.

    Google Scholar 

  28. BIKOFF, E. K., L. Y. HUANG, V. EPISKOPOU, J. MEERWIJK, R. N. GERMAIN, and E. J. ROBERTSON. 1998. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699-1712.

    Google Scholar 

  29. MIYAZAKI, T., P. WOLF, S. TOURNE, C. WALZINGER, A. DIERICH, N. BAROIS, H. PLOEGH, C. BENOIST, and D. MATHIS. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell 84:531-541.

    Google Scholar 

  30. FUNG-LEUNG, W. P., C. D. X. M. SURH, J. PANG, D. LETURCQ, P. A. PETERSON, S. R. WEBB, and L. KARLSSON. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science 271:1278-1281.

    Google Scholar 

  31. MARTIN, W. D., G. G. HICKS, H. I. LEVA, H. E. RULEY, and L. VAN KAER. 1998. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell 84:543-550.

    Google Scholar 

  32. KARLSSON, L., A. PELERAUX, R. LINDSTEDT, M. LILJEDAHL, and P. A. PETERSON. 1994. Reconstitution of an operational MHC Class II compartment in nonantigen-presenting cells. Science 266:1569-1573.

    Google Scholar 

  33. RASCHKE, W. C., S. BAIRD, P. RALPH, and I. NOKOINZ. 1978. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15:261.

    Google Scholar 

  34. OI, V. T., P. P. JONES, J. W. GODING, and L. A. HERZENBERG. 1978. Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens. In: Lymphocyte Hybridomas, Melchers, F., M. Potter, and N. Warner, Editors: Springer Verlag. New York. pp. 115-237.

    Google Scholar 

  35. NATHAN, C. F. and J. B. HIBBS, JR. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65-70.

    Google Scholar 

  36. STUEHR, D. J., S. S. GROSS, I. SAKUMA, R. LEVI, and C. F. NATHAN. 1989. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169:1011-1020.

    Google Scholar 

  37. KHAIR-EL-DIN, T. A., S. C. SICHER, M. A. VAZQUEZ, W. J. WRIGHT, and C. Y. LU. 1995. Docosahexaenoic acid, a major constituent of fetal serum and fish oil diets, inhibits IFN gamma induced Ia-expression by murine macrophages in vitro. J. Immunol. 154:1296-1306.

    Google Scholar 

  38. DANIELSON, P. E., S. FORSS-PETTER, M. A. BROW, L. CALAVETTA, J. DOUGLASS, R. J. MILNER, and J. G. SUTCLIFFE. 1988. p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA 7:261-267.

    Google Scholar 

  39. CHANG, C. H., J. D. FONTES, M. PETERLIN, and R. A. FLAVELL. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367-1374.

    Google Scholar 

  40. KHAIR-EL-DIN, T. A., S. C. SICHER, M. A. VAZQUEZ, G. W. CHUNG, K. L. STALLWORTH, K. KITAMURA, R. T. MILLER, and C. Y. LU. 1996. Transcription of the murine iNOS gene is inhibited by docosahexaenoic acid, a major constituent of fetal and neonatal sera as well as fish oils. J. Exp. Med. 183:1241-1246.

    Google Scholar 

  41. ESTESS, P., A. B. BOGOVICH, M. KOO, P. P. JONES, and H. O. MCDEVITT. 1986. Sequence analysis and structure-function correlations of murine q, k, u, s and f haplotype I-A beta cDNA in pBSKII. Proc. Natl. Acad. Sci. U.S.A. 83:3594-3598.

    Google Scholar 

  42. CHANG, C. H., S. GUERDER, S. C. HONG, W. VAN EWIJK, and R. A. FLAVELL. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC Class II expression. Immunity 4:167-178.

    Google Scholar 

  43. GLIMCHER, L. H. and C. J. KARA. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13-49.

    Google Scholar 

  44. NOACK, E. and M. FEELISCH. 1991. Molecular mechanisms of nitrovasodilator bioactivation. Basic Res. Cardiol. 86(suppl 2):37-50.

    Google Scholar 

  45. CHANG, C. H. and R. A. FLAVELL. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181:765-767.

    Google Scholar 

  46. CRESSWELL, P. 1994. Assembly, transport, and function of MHC class II molecules. Annu. Rev. Immunol. 12:259-293.

    Google Scholar 

  47. TOURNE, S., T. MIYAZAKI, A. OXENIUS, L. KLEIN, T. FEHR, B. KYEWSKI, C. BENOIST, and D. MATHIS. 1997. Selection a broad repertoire of CD4+ T cells in H-2Ma 0 0 mice. Immunity 7:187-195.

    Google Scholar 

  48. MARCINKIEWICZ, J., A. GRABOWSKA, and B. CHAIN. 1995. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol. 25:947-951.

    Google Scholar 

  49. TUCKER, S. D., M. R. SIVARAMAKRISHNAN, J. KLOSTERGAARD, and G. LOPEZ-BERESTEIN. 1991. Independence of the pattern of early cytokine release from autoregulation by nitric oxide. J. Leuko. Biol. 50:509.

    Google Scholar 

  50. EIGLER, A., B. SINHA, and S. ENDRES. 1993. Nitric oxide-releasing agents enhance cytokine-induced tumor necrosis factor synthesis in human mononuclear cells. Biochem. Biophys. Res. Commun. 196:494.

    Google Scholar 

  51. DUSTIN, L. B., SOBRMAN, R., C. M. SHEA, and C. Y. LU. 1990. Docosahexaenoic acid, a constituent of rodent fetal serum and fish oil diets, inhibits acquisition of macrophage tumoricidal function. J. Immunol. 144:4888-4897.

    Google Scholar 

  52. BOSS, J. M. 1997. Regulation of transcription of MHC class II genes. Curr. Opin. Immunol. 9:107-113.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kielar, M.L., Sicher, S.C., Penfield, J.G. et al. Nitric Oxide Inhibits INFγ-induced Increases in CIITA mRNA Abundance and Activation of CIITA Dependent Genes—Class II MHC, Ii and H-2M. Inflammation 24, 431–445 (2000). https://doi.org/10.1023/A:1007012128392

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007012128392

Keywords

Navigation